Being one of the most important studies we have read, we will take the time to explain all the concepts, one by one.
2) ๐๐๐๐ฉ ๐๐ง๐ ๐ผ๐ช๐ฉ๐ค๐ฅ๐๐๐๐ค๐จ๐ค๐ข๐๐จ ?
Autophagosomes are double-membrane vesicles formed during autophagy, that sequester cytoplasmic cargo like proteins, organelles and pathogens targeted for degradation.
Upon SARS-CoV-2 invasion, host cells induce autophagy ...
3) ...as an intrinsic antiviral defense mechanism. Autophagosomes capture invading viral particles and components.
Cargo-loaded autophagosomes then fuse with lysosomes. This degrades intact virions and disrupts infection.
4) ๐๐๐๐ฉ ๐๐ง๐ ๐๐ฎ๐จ๐ค๐จ๐ค๐ข๐๐จ ?
Lysosomes are membrane-bound organelles that contain digestive enzymes and maintain an acidic pH optimal for degradation. As part of the autophagy response, SARS-CoV-2 virions and viral components that are sequestered inside autophagosomes
5) ...are delivered to lysosomes upon fusion.
The acidic pH and hydrolases inside lysosomes promote destruction of viral structural proteins, genetic material, lipids etc. This degrades and destroys intact virions.
6) ๐๐๐๐ฉ ๐๐จ ๐๐ฎ๐จ๐ค๐จ๐ค๐ข๐๐ก ๐๐๐๐ง๐๐๐๐ฉ๐๐ค๐ฃ ๐ค๐ ๐๐ผ๐๐-๐พ๐ค๐-2 ?
It refers to the process by which the virus is targeted to lysosomes and broken down through the cell's lysosomal machinery.
And finally, ๐ผ๐ช๐ฉ๐ค๐ฅ๐๐๐๐ฎ ๐๐ฃ๐๐ช๐๐ฉ๐๐ค๐ฃ refers to ...
7) ... the activation of this autophagy process in response to the infection caused by the SARS-CoV-2 virus.
After this short presentation, we can now present this study
8) The Omicron variant of SARS-CoV-2 is more resistant to autophagy induction compared to early 2020 SARS-CoV-2 strains and the Delta variant. Activation of autophagy reduced replication of early strains and Delta more strongly.
9) Mutation T9I in the SARS-CoV-2 envelope (E) protein conferred increased autophagy resistance to Omicron variants compared to strains without this mutation.
10) E mutation T9I leads to increased accumulation of autophagosomes by more strongly inhibiting autophagic flux. It interacts more with components of the autophagosome assembly machinery.
11) Viral particles containing E T9I were less sensitive to autophagy induction upon entry compared to particles with E T9. However, E T9I did not alter particle assembly or infectivity.
12) Rare Omicron isolates retaining the ancestral E T9 were more sensitive to autophagy induction compared to E T9I isolates. Recombinant early SARS-CoV-2 gained autophagy resistance by acquiring E T9I.
13) In summary, the study identifies E T9I as a mutation that allows Omicron to escape autophagy, which may have contributed to its emergence and spread by evading this innate immune defense. Acquiring resistance to autophagy is an evolutionary adaptation of SARS-CoV-2.
In several threads, we indicated that this E:T9I mutation by reducing the pathogenicity of Omicrons had changed the face of the pandemic.
There was a sort of trade-off among the Omicrons ...
15) ... less pathogenic but more infectious with better immune escape thanks to Spike mutations.
Omicron was therefore more dangerous, which is the case for a more infectious and less pathogenic virus.
16) As we discovered that E:T9I may have contributed to the emergence and spread of Omicrons by evading the innate immune defense, it is really a key evolutionary adaptation of SARS-CoV-2.
Thanks for reading ๐
H/t @DavidJoffe64 @siamosolocani @C_A_G0101
@mrmickme @DrInfoSec
โข โข โข
Missing some Tweet in this thread? You can try to
force a refresh
WHY is it IMPOSSIBLE to COMPLETELY ELIMINATE the SARS-CoV-2 virus?
What causes the virus or its remnants to linger in our bodies even after a mild or asymptomatic infection?
(1st part : "The persistence")
This discussion will address these questions through multiple threads...
2) ...drawing from a wealth of published research due to the intricacy of the topic.
To start, weโll present a concise overview of five key studies that demonstrate the virus's persistence for weeks or even months following infection.
"Now this is not the end. It is not even the beginning of the end" (Winston Churchill)
This study shows that the Sarbecoviruses have the capacity to generate new variants rapidly, with RBD of two novel viral groups exhibiting high similarity to SARS-CoV-2 biorxiv.org/content/10.110โฆ
2) Over 3 years, researchers sampled 1,462 bats in Cambodia Steung Treng province, identifying extensive and diverse coronaviruses co-circulation. Using metatranscriptomic and amplicon sequencing, they generated 33 complete sarbecovirus genomes.
4) This study suggests that the viral family of Sarbecoviruses can reserve some unpleasant surprises, and quite rapidly:
โถ๏ธ They emphasize the "significant pandemic threat" posed by the genetic diversity and evolutionary dynamics of circulating bat coronaviruses.
Doctor, I'm confused ๐ค
I have a high level of antibodies, yet I'm still experiencing long COVID. Why is that?
"The ANTIBODIES PARADOX in LONG COVID Condition: Unraveling the Disconnect Between Humoral Immunity and Chronic Illness" nature.com/articles/s4146โฆ
2) The finding in this study of persistently higher anti-N antibody levels in people with Post-Covid Condition (PCC) compared to those with acute infection only, does seem paradoxical at first glance.
3) A few points on this:
โถ๏ธ The study suggests this may indicate "altered immune activation or viral persistence" in people with PCC, rather than just a stronger antibody response per se.
2) T-cells are like the superheroes of our immune system - they work hard to protect us from germs and viruses.
When a virus like SARS-COV-2 gets into our body, the T cells spring into action. There are different types of T cells, each with a special job to do.
3) - Some T cells are like the fighters, killing off the virus-infected cells.
- Other T cells are the coordinators, telling the other immune cells what to do.
- There are also T cells that act like the police, making sure the immune response doesn't go overboard.
2) The most important immune components in the nasal tissue for fighting COVID-19 are:
โถ๏ธ Monocytes and neutrophils
- These immune cells moved into the area under the nose lining during active COVID-19 infection and helped protect the underlying lymphoid tissue.
3)โถ๏ธ Macrophages
- As people recovered from COVID-19, macrophages started to help repair the nasal tissue.
โถ๏ธ Germinal centers and B cells
- The specialized germinal center structures in the nose contained active B cells that were producing antibodies against the COVID-19 virus
How SARS-COV-2 spreads (Re) and why there are differences between countries ?
An explanation for kids based on the astonishing new study of @firefoxx66 @richardneher and colleagues pubmed.ncbi.nlm.nih.gov/40233303/
2) With a really fast-spreading virus going around, like the one that causes COVID-19, when someone gets sick, they can pass the virus to other people. But some sick people end up spreading it to a lot more people than others.
2) The scientists in this study wanted to figure out how the virus is spreading and how much it's spreading from person to person. To do this, they looked at the genetic code, or the "DNA", of the virus.
Whenever the virus infects someone new, it can change a little bit.